Screener
AbCellera Biologics Inc. ABCL Finite-Lived Intangible Assets, Accumulated Amortization
Finite-Lived Intangible Assets, Accumulated Amortization at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization.
The source filing: AbCellera Biologics Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:28 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001703057-26-000046
| Line item | December 31, 2025 / Grosscarryingamount | December 31, 2025 / Accumulatedamortization | December 31, 2025 / Net bookvalue | June 30, 2026 / Grosscarryingamount | June 30, 2026 / Accumulatedamortization | June 30, 2026 / Net bookvalue |
|---|---|---|---|---|---|---|
| License | $16,620 | $8,968 | $7,652 | $16,620 | $9,785 | $6,835 |
| Technology | 52,700 | 21,971 | 30,729 | 52,700 | 23,005 | 29,695 |
| Total | $69,320 | $30,939 | $38,381 | $69,320 | $32,790 | $36,530 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is AbCellera Biologics Inc.'s finite-lived intangible assets, accumulated amortization?
- AbCellera Biologics Inc. (ABCL) reported finite-lived intangible assets, accumulated amortization of $32.79M in Q2 2026.
- How has AbCellera Biologics Inc.'s finite-lived intangible assets, accumulated amortization changed year-over-year?
- AbCellera Biologics Inc.'s finite-lived intangible assets, accumulated amortization decreased by 35.5% year-over-year, from $50.87M to $32.79M.
- What is the long-term trend for AbCellera Biologics Inc.'s finite-lived intangible assets, accumulated amortization?
- Over 2 years (2023 to 2025), AbCellera Biologics Inc.'s finite-lived intangible assets, accumulated amortization has grown at a -5.6% compound annual growth rate (CAGR), from $34.72M to $30.94M.
- What does finite-lived intangible assets, accumulated amortization mean?
- Finite-Lived Intangible Assets, Accumulated Amortization
Ask your AI about AbCellera Biologics Inc.'s finite-lived intangible assets, accumulated amortization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude